Wim Boersma

4.7k citations

82 papers · 2.1k indexed · h-index 25

Pulmonary and Respiratory Medicine top 1%
Epidemiology top 5%
Physiology top 5%
Emergency Medical Services top 2%
Surgery

Co-authors: Josje Altenburg Tjip S. van der Werf Casper S. de Graaff Johannes M. A. Daniels Ymkje Stienstra Jacobus H Sloos E.H.J. van Haren Dominic Snijders
Topics: Cystic Fibrosis Research Advances (31 papers)Chronic Obstructive Pulmonary Disease (COPD) Research (27 papers)Asthma and respiratory diseases (17 papers)
Cited by: Pulmonary and Respiratory Medicine Emergency Medical Services Critical Care and Intensive Care Medicine
Journals: JAMA PLoS ONE American Journal of Clinical Nutrition
Partner nations: Netherlands Spain Italy

In The Last Decade

Wim Boersma

80 papers receiving 2.1k citations

Peers

Countries citing papers authored by Wim Boersma

Since Specialization

Citations

This map shows the geographic impact of Wim Boersma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wim Boersma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wim Boersma more than expected).

Fields of papers citing papers by Wim Boersma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wim Boersma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wim Boersma. The network helps show where Wim Boersma may publish in the future.

Co-authorship network of co-authors of Wim Boersma

This figure shows the co-authorship network connecting the top 25 collaborators of Wim Boersma. A scholar is included among the top collaborators of Wim Boersma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wim Boersma. Wim Boersma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effect of maintenance azithromycin on radiological features in patients with bronchiectasis - Analysis from the BAT randomized controlled trial 2021 ·Respiratory Medicine ·(unknown),Josje Altenburg,Firdaus A. Mohamed Hoesein,Inez Bronsveld,(unknown),(unknown),Pim A. de Jong,Harry Heijerman,Wim Boersma	4
2	Identifying a nasal gene expression signature associated with hyperinflation and treatment response in severe COPD 2020 ·Scientific Reports ·Alen Faiz,(unknown),Erica van der Wiel,Ilse M. Boudewijn,Gerard H. Koppelman,Corry‐Anke Brandsma,Huib A.M. Kerstjens,Wim Timens,(unknown),Henk Pasma,Wim Boersma,Pascal Wielders,(unknown),Khaled Mansour,Katrina Steiling,Avrum Spira,Marc E. Lenburg,Irene H. Heijink,Dirkje S. Postma,Maarten van den Berge	91
3	Collagen Degradation and Formation Are Elevated in Exacerbated COPD Compared With Stable Disease 2018 ·CHEST Journal ·Desirée Schumann,Diana Julie Leeming,Eleni Papakonstantinou,Francesco Blasi,Κonstantinos Κostikas,Wim Boersma,Renaud Louis,Branislava Milenković,Joachim G.J.V. Aerts,Jannie Marie Bülow Sand,Emiel F.�M. Wouters,Gernot Rohde,(unknown),Antoní Torres,Tobias Welte,Michael Tamm,M.A. Karsdal,Daiana Stolz	39
4	Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPD 2017 ·Respiratory Medicine ·(unknown),(unknown),René Lutter,Johannes M. A. Daniels,Paul van der Valk,Margreet Schoorl,Huib A.M. Kerstjens,Tjip S. van der Werf,Wim Boersma	36
5	Non-cystic fibrosis bronchiectasis: clinical presentation, diagnosis and treatment, illustrated by data from a Dutch Teaching Hospital. 2015 ·PubMed ·Josje Altenburg,(unknown),Tjip S. van der Werf,Wim Boersma	19
6	Mannose-binding lectin protein and its association to clinical outcomes in COPD: a longitudinal study 2015 ·Respiratory Research ·Jyotshna Mandal,Bijaya Malla,Rudi Steffensen,Luigi Costa,Adrian Egli,Marten Trendelenburg,Francesco Blasi,Κonstantinos Κostikas,Tobias Welte,Antoní Torres,Renaud Louis,Wim Boersma,Branislava Milenković,Joachim G.J.V. Aerts,Gernot Rohde,Alícia Lacoma,Katharina Rentsch,Michael Roth,Michael Tamm,Daiana Stolz	15
7	Adrenomedullin optimises mortality prediction in COPD patients 2015 ·Respiratory Medicine ·Marjolein Brusse‐Keizer,(unknown),Job van der Palen,(unknown),Huib A.M. Kerstjens,Wim Boersma,Francesco Blasi,Κonstantinos Κostikas,Branislava Milenković,Michael Tamm,Daiana Stolz	15
8	COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study 2014 ·European Respiratory Journal ·Daiana Stolz,Renaud Louis,Wim Boersma,Branislava Milenković,Κonstantinos Κostikas,Francesco Blasi,Joachim G.J.V. Aerts,Gernot Rohde,Alicia Marín,Lucas Boeck,Janko Rakic,Andreas Scherr,Antoní Torres,Tobias Welte,Michael Tamm	3
9	Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials 2014 ·The Lancet Respiratory Medicine ·Alan F. Barker,Anne E. O’Donnell,Patrick A. Flume,Philip J. Thompson,(unknown),Javier de Gracia,Wim Boersma,Anthony De Soyza,Lixin Shao,Jenny Zhang,(unknown),Sandra A. Lewis,(unknown),A. Bruce Montgomery,Matthew McKevitt,David Gossage,Alexandra L. Quittner,Thomas G. O’Riordan	153
10	Exertional Hypoxemia in Stable COPD Is Common and Predicted by Circulating Proadrenomedullin 2014 ·CHEST Journal ·Daiana Stolz,Wim Boersma,Francesco Blasi,Renaud Louis,Branislava Milenković,Κonstantinos Κostikas,Joachim G.J.V. Aerts,Gernot Rohde,Alícia Lacoma,Janko Rakic,Lucas Boeck,Paola Castellotti,Andreas Scherr,Alicia Marín,Sabine Hertel,Sven Giersdorf,Antoní Torres,Tobias Welte,Michael Tamm	22
11	Two phase 3 placebo-controlled trials of aztreonam lysine for inhalation (AZLI) for non-cystic fibrosis bronchiectasis (NCFB) 2013 ·European Respiratory Journal ·Alan R. Barker,Anne O’Donnell,Philip J. Thompson,Patrick A. Flume,(unknown),Javier de Gracia,Wim Boersma,Eva Polverino,Lixin Shao,Jenny Zhang,(unknown),(unknown),Matt McKevitt,A. Bruce Montgomery,Alexandra L. Quittner,David Gossage,Thomas G. O’Riordan	10
12	Eosinophilia as marker of outcome in hospitalised patients with AECOPD 2013 ·European Respiratory Journal ·Henk‐Jan Prins,Dominic Snijders,Johannes M. A. Daniels,Wim Boersma	1
13	Transient impairment of reticulocyte hemoglobin content and hepcidin-25 induction in patients with community-acquired pneumonia 2012 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Margreet Schoorl,Dominic Snijders,Marianne Schoorl,Wim Boersma,P. C. M. Bartels	10
14	Long term azithromycin treatment: A randomised placebo-controlled trial in non-CF bronchiectasis; results from the BAT trial 2011 ·European Respiratory Journal ·Josje Altenburg,(unknown),Tjip S. van der Werf,Wim Boersma	7
15	Immunomodulatory Effects of Macrolide Antibiotics – Part 2: Advantages and Disadvantages of Long-Term, Low-Dose Macrolide Therapy 2010 ·Respiration ·Josje Altenburg,Casper S. de Graaff,Tjip S. van der Werf,Wim Boersma	63
16	Antibiotics in Addition to Systemic Corticosteroids for Acute Exacerbations of Chronic Obstructive Pulmonary Disease 2009 ·American Journal of Respiratory and Critical Care Medicine ·Johannes M. A. Daniels,Dominic Snijders,Casper S. de Graaff,F. Vlaspolder,Henk M. Jansen,Wim Boersma	99
17	Sputum colour reported by patients is not a reliable marker of the presence of bacteria in acute exacerbations of chronic obstructive pulmonary disease 2009 ·Clinical Microbiology and Infection ·Johannes M. A. Daniels,Casper S. de Graaff,F. Vlaspolder,Dominic Snijders,HM Jansen,Wim Boersma	24
18	Rituximab in life threatening antisynthetase syndrome 2009 ·Rheumatology International ·(unknown),J.C. Grutters,Josje Altenburg,Wim Boersma,E. J. ter Borg,Jules M.M. van den Bosch	55
19	Incidence and completeness of notification of Legionnaires' disease in The Netherlands: covariate capture–recapture analysis acknowledging regional differences 2007 ·Epidemiology and Infection ·(unknown),Christian J. P. A. Hoebe,Jeroen W. Den Boer,Jeroen K. Vermunt,E. P. F. IJzerman,Wim Boersma,Jan Hendrik Richardus	16
20	A preliminary evaluation of a new enzyme immunoassay to detect Chlamydia pneumoniae-specific antibodies 2000 ·Journal of Microbiological Methods ·Jacobus M. Ossewaarde,Tamara Tuuminen,Wim Boersma,M Sandström,(unknown),Jens Boman	11

About Wim Boersma

Wim Boersma is a scholar working on Pulmonary and Respiratory Medicine, Emergency Medical Services and Critical Care and Intensive Care Medicine, having authored 82 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (31 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (27 papers) and Asthma and respiratory diseases (17 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.5k citations), Emergency Medical Services (161 citations) and Critical Care and Intensive Care Medicine (93 citations). Wim Boersma has collaborated with scholars based in Netherlands, Spain and Italy. Frequent co-authors include Josje Altenburg, Tjip S. van der Werf, Casper S. de Graaff, Johannes M. A. Daniels, Ymkje Stienstra, Jacobus H Sloos, E.H.J. van Haren, Dominic Snijders, Henk M. Jansen and Marianne Schoorl. Their work appears in journals such as JAMA, PLoS ONE and American Journal of Clinical Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact